CNTP2抗体;CNTP2 Antibody—艾普蒂 新品

+ +

•  

   

     Gel: 8%SDS-PAGE, Lysate: 40 μg, Lane: Human breast infiltrative duct tissue, Primary antibody: P12105(RHCE Antibody) at dilution 1/250, Secondary antibody: Goat anti rabbit IgG at 1/8000 dilution, Exposure time: 5 minutes    

  
  

CNTP2 antibody is a research tool designed to target and detect the CNTNAP2 protein (Contactin-Associated Protein-like 2), a member of the neurexin superfamily implicated in neural development and synaptic function. CNTNAP2 is highly expressed in the nervous system, particularly in neurons, and plays a critical role in cell adhesion, axon guidance, and the formation of myelinated axons. It has garnered significant attention due to its association with neurodevelopmental disorders, including autism spectrum disorder (ASD), epilepsy, schizophrenia, and language impairments. Genetic studies have linked mutations or variations in the CNTNAP2 gene to altered neuronal connectivity and communication, making it a key focus in neurobiology and disease research.

The CNTP2 antibody is commonly used in immunohistochemistry (IHC), Western blotting, and immunofluorescence to study CNTNAP2 expression, localization, and interactions in both human and animal models. Researchers employ it to investigate how CNTNAP2 dysfunction contributes to pathological mechanisms, such as disrupted synaptic plasticity or impaired neuronal networks. Its utility extends to preclinical studies exploring biomarkers or therapeutic targets for neuropsychiatric conditions. As an essential reagent, the antibody’s specificity and validation are crucial for ensuring reliable experimental outcomes. Ongoing research with CNTP2 antibodies continues to unravel the protein’s role in brain development and disease, bridging gaps between genetic findings and functional neurobiology.